Ladenburg Thalmann Financial Services’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $140K | Buy |
2,417
+9
| +0.4% | +$521 | ﹤0.01% | 2778 |
|
2019
Q3 | $145K | Buy |
2,408
+712
| +42% | +$42.9K | ﹤0.01% | 2686 |
|
2019
Q2 | $95K | Sell |
1,696
-207
| -11% | -$11.6K | ﹤0.01% | 3001 |
|
2019
Q1 | $98K | Sell |
1,903
-86
| -4% | -$4.43K | ﹤0.01% | 2897 |
|
2018
Q4 | $92K | Buy |
1,989
+1,216
| +157% | +$56.2K | ﹤0.01% | 2806 |
|
2018
Q3 | $51K | Sell |
773
-492
| -39% | -$32.5K | ﹤0.01% | 3296 |
|
2018
Q2 | $71K | Hold |
1,265
| – | – | ﹤0.01% | 3008 |
|
2018
Q1 | $71K | Sell |
1,265
-180
| -12% | -$10.1K | ﹤0.01% | 3008 |
|
2017
Q4 | $68K | Buy |
1,445
+98
| +7% | +$4.61K | ﹤0.01% | 3014 |
|
2017
Q3 | $68K | Sell |
1,347
-1,064
| -44% | -$53.7K | ﹤0.01% | 2864 |
|
2017
Q2 | $132K | Buy |
2,411
+106
| +5% | +$5.8K | ﹤0.01% | 2333 |
|
2017
Q1 | $97K | Sell |
2,305
-1,089
| -32% | -$45.8K | ﹤0.01% | 2420 |
|
2016
Q4 | $100K | Buy |
3,394
+1,484
| +78% | +$43.7K | ﹤0.01% | 2328 |
|
2016
Q3 | $79K | Buy |
1,910
+8
| +0.4% | +$331 | ﹤0.01% | 2420 |
|
2016
Q2 | $76K | Buy |
1,902
+88
| +5% | +$3.52K | ﹤0.01% | 2355 |
|
2016
Q1 | $61K | Buy |
1,814
+136
| +8% | +$4.57K | ﹤0.01% | 2431 |
|
2015
Q4 | $56K | Hold |
1,678
| – | – | ﹤0.01% | 2472 |
|
2015
Q3 | $50K | Sell |
1,678
-262
| -14% | -$7.81K | ﹤0.01% | 2468 |
|
2015
Q2 | $51K | Buy |
1,940
+51
| +3% | +$1.34K | ﹤0.01% | 2569 |
|
2015
Q1 | $47K | Buy |
1,889
+587
| +45% | +$14.6K | ﹤0.01% | 2596 |
|
2014
Q4 | $30K | Buy |
1,302
+431
| +49% | +$9.93K | ﹤0.01% | 2704 |
|
2014
Q3 | $18K | Hold |
871
| – | – | ﹤0.01% | 2744 |
|
2014
Q2 | $17K | Hold |
871
| – | – | ﹤0.01% | 2771 |
|
2014
Q1 | $16K | Sell |
871
-364
| -29% | -$6.69K | ﹤0.01% | 2707 |
|
2013
Q4 | $25K | Buy |
1,235
+188
| +18% | +$3.81K | ﹤0.01% | 2393 |
|
2013
Q3 | $19K | Hold |
1,047
| – | – | ﹤0.01% | 2484 |
|
2013
Q2 | $16K | Buy |
+1,047
| New | +$16K | ﹤0.01% | 2463 |
|